| Additional Data | |
|---|---|
| 2,701.00Open Price | 3,572,942Volume |
| 2,695.00Previous Close | 4305Trades |
| 2,717.50High | 2,966.00Years High |
| 2,687.00Low | 2,126.00Years Low |
| ShareStock Type | GBXCurrency |
| GBRCountry | LSEExchange |
| GB0009895292ISIN | AZNSymbol |
| Today: | -0.42% | 2,706.50 |
| Perf. 30 days: | -0.85% | 2,718.13 |
| Perf. 180 days: | -6.77% | 2,890.68 |
| Perf. 360 days: | +4.48% | 2,579.37 |
| Perf. current year: | +4.55% | 2,577.59 |
| 15/11/09 | GSK plans to cut drug production waste FT.com |
| 13/11/09 | New year, new outlook on payouts FT.com |
| 04/11/09 | Roll up for Japan's medical mystery tour FT.com |
| 03/11/09 | Novartis to expand Chinese research labs FT.com |
| 29/10/09 | AZ to settle US marketing case FT.com |
| 28/10/09 | Financial and mining losses hit FTSE FT.com |
| 25/10/09 | J&J wants deals with rivals to share risk FT.com |
| 25/10/09 | AstraZeneca to draw on car plant expertise FT.com |
| 22/10/09 | Novartis warns on currency blow to profits FT.com |
| 21/10/09 | Swine flu jabs programme begins FT.com |
| 15/10/09 | Tamiflu boosts Roche sales figures FT.com |
| 09/10/09 | Equity income funds set for comeback FT.com |
| 30/09/09 | Pharmaceuticals: Same end, entirely different mean FT.com |
| 28/09/09 | J&J buys 18% stake in Crucell FT.com |
| 25/09/09 | Prepare to surf a wave of mergers FT.com |